Skip to main content
eNeurologicalSci logoLink to eNeurologicalSci
. 2015 Aug 17;1(1):12–20. doi: 10.1016/j.ensci.2015.08.002

Diversity of approaches in assessment of executive functions in stroke: Limited evidence?

Juliana Conti a,, Annette Sterr a,b, Sônia Maria Dozzi Brucki a, Adriana B Conforto a,c
PMCID: PMC4662603  NIHMSID: NIHMS725839  PMID: 26623442

Abstract

Stroke is a leading cause of disability worldwide. Cognitive functions and, in particular, executive function, are commonly affected after stroke, leading to impairments in performance of daily activities, decrease in social participation and in quality of life. Appropriate assessment and understanding of executive dysfunction are important, firstly to develop better rehabilitation strategies for executive functions per se and secondly to consider executive function abilities on rehabilitation strategies in general. The purpose of this review was to identify the most widely used assessment tools of executive dysfunction for patients with stroke, and their psychometric properties.

We systematically reviewed manuscripts published in English in databases from 1999 to 2015. We identified 35 publications. The most frequently used instruments were the Stroop, Digit Span and Trail making tests. Psychometric properties were described for the Executive Function Performance Test, Executive Clock Drawing Task, Chinese Frontal Assessment Battery and Virtual Action Planning — Supermarket, and two subtests of the Cambridge Cognitive Examination — Revised.

There is a paucity of tools to reliably measure executive dysfunction after stroke, despite the fact that executive dysfunction is frequent. Identification of the best tools for executive dysfunction assessment is necessary to address important gaps in research and in clinical practice.

Keywords: Stroke, Executive function, Evaluation methodology, Cognition

1. Introduction

Stroke is characterized by fast and focal development of neurologic symptoms that reflect loss of brain function due to ischemia or hemorrhage [1], [2]. Strokes were responsible for 10% of all world deaths and 4% of loss of disability-adjusted life years in 2010 [3]. While age-standardized incidence of stroke significantly decreased by 12% in high-income countries, it increased by 12% in low-middle income countries between 1990 and 2010 [3]. Also, the number of stroke survivors increased by 84% in low- and middle-income countries between 1990 and 2010 [3].

More than two-thirds of patients with stroke have limitations to live independently. Stroke can cause a catastrophic impact in patients' lives, due to impairments in physical and psychological functions, as well as in cognitive, perceptual and communication skills [4]. Burden is not only caused by the direct deficits caused by acute stroke, but also by dementia. In a recent meta-analysis, rates of dementia after stroke varied from 9.1% (in population-based studies) to 14.4%, (in hospital-based studies) [5].

Cognitive dysfunction strongly contributes to disability and loss in quality of life. It can also often be a barrier for returning to work. Because cognitive impairments are ‘invisible’, patients have less awareness of them and it is more difficult to recognize the deficits in the workplace so that the necessary adjustments can be made. Studies in post-stroke patients often report scores in the Mini-Mental State Examination (MMSE) for cognitive evaluation, but this test is insensitive to detect executive dysfunction and does not capture more subtle deficits in cognition [5].

When a comprehensive assessment of cognition was performed in a multicenter study in Belgium and the Netherlands, dysfunction was present in 55% (89/190) of individuals after stroke. The following functions were compromised: executive function (39.1%), visual perception and construction (38.1%), neglect (31.3%), abstract reasoning (25.6%), verbal memory (25.6%), language (25.6%) and visual memory (22.0%) [6]. Another study from New Zealand showed that 30–50% of 307 patients had impaired cognitive performance [7]. The most common deficit was executive dysfunction (30.4%). The prevalence of executive dysfunction after stroke ranges from 18.5% to 39%, depending on definitions and instruments used for its evaluation [6], [8], [9].

Executive function involves planning, problem solving, dealing with new situations, decision-making and performing complex tasks [10]. These functions are part of the cognitive process of acquiring, keeping and applying knowledge to behavior [11]. Theories about executive function have been proposed: (1) Single system: believes that injury of a single executive function process leads to impairment; (2) Construct-led: working-memory and fluid-intelligence are the most important functions; (3) Multiple process: Executive functions are composed of different functions and processes working together during daily activities, but it is possible to evaluate each function separately; and (4) Single-symptoms: there are two symptoms that are common in patients with EF deficits: confabulation (characterized by impairment in memory control) and multitasking (patients with impairments in higher-level functions, leading to a problems in organizing/planning daily routines) [11]. Executive function roles can also be divided into: (1) shifting: the capacity to initiate different tasks at the same time and return to each one; (2) updating: to monitor information and organize it according to a different objective, and retrieve it when necessary; and (3) inhibition: to inhibit one stimulus and focus on a task or problem [12]. These three functions are connected and can interfere with one another. Moreover, they contribute to performance of more complex executive functions and influence rehabilitation outcomes [12], [13].

We conducted a review of the literature about tools for assessment of executive functions in stroke to identify tests performed in common practice worldwide and to determine the most appropriate evaluation instruments according to their psychometric properties, using an evidence-based approach.

2. Methods

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses — PRISMA [14]. One investigator reviewed the manuscripts. Manuscripts published in English in Medline, Pubmed and Google Scholar from 1999 to 2015 were searched using the terms “stroke” and each of the following: executive function, executive dysfunction, working memory, rehabilitation or cognition. During the research we also considered the title, key word and abstract of the papers before including them in this review. Only original papers were considered.

We only included studies in which the primary goal was assessment of executive dysfunction in adults (18-90 years). Abstracts that did not specifically report the assessment of executive function or executive dysfunction, or in which executive function or dysfunction were not the primary objective, were excluded. Abstracts reporting on a mix of neurological disorders rather than stroke specifically were also not included. For those abstracts fulfilling the inclusion criteria, the full manuscripts were obtained to extract the methodological details listed below. In addition to the manuscripts identified by the key word search, we also included papers cited in other systematic reviews or meta-analysis.

We checked frequencies of use of the different tools of evaluation across studies. In addition, tools for evaluation of executive dysfunction were grouped in tables according to time from stroke described in the studies: less than one month, one-six months and six months or more. Table 1, Table 2, Table 3, Table 4 describe: (1) references, including authors and country of research; (2) instruments used for executive function assessment; (3) objective; (4) sample characteristics, taken from the methods sections of the original papers; including whether or not performance of patients was compared to performance of controls and if the lesion site was described; (5) psychometric data of the instruments: internal consistency (Cronbach's α), reliability (test–retest and inter-rater; intraclass correlation coefficient, ICC, or Pearson's r), concurrent validity (evaluated with Spearman's rho or Pearson's r) [15], and (6) main results: the relation between executive dysfunction and other conditions (such as depression or motor function). Table 5 describes the abbreviations of the tools listed in Table 1, Table 2, Table 3, Table 4.

Table 1.

Assessment tools for executive dysfunction, evaluated in patients < 1 month after stroke.

Article, country Tools Objective Sample characteristics Psychometric Data Main Results
[18]
Brazil
DS, VFT and TMT Relation between depression-executive dysfunction syndrome and patients with stroke First-ever ischemic stroke (n = 87), with subgroups: older (> 60 y; n = 62) and younger (≤ 60 y; n = 25)
Stroke affecting the LCSPT (n = 27) or not (n = 48)
Not reported Depression-executive dysfunction syndrome significantly more frequent in younger than in older subgroup
[16]
France
DS, VFT, TMT, M-WCST, Tower of London Test and Stroop Test Relation between working memory and EF Frontal strokes
(n = 17, mean age, 47 y); “posterior” strokes
(n = 12, mean age, 43.3 y)
CG (n = 29, mean age, 46.3 y)
Not reported Both groups had impaired working memory
[23]
United States
TMT and DS Effects of stroke on TMT and DS performance. Determine whether patients with frontal lesions have poorer performance on TMT B and DS than patients with non-frontal brain lesions TMT: non-frontal lesions (n = 122) and frontal lesions
(n = 4).
DS: Non-frontal (n = 175) and frontal lesions (n = 52).
Not reported TMT A and B as well as DS forward and backwards scores similar for patients with frontal and non-frontal lesions; no relations between test performance and stroke severity
[26]
Sweden
EFPT and AMPS Concurrent validity Stroke (n = 23) Concurrent validity:
rho = 0.61
Subtests: Cooking Task: ICC = 0.54, Paying bills task: ICC = 0.57, Medication task: ICC = 0.56 and Telephone task: ICC = 0. All tasks of EFPT: rho = 0.60
[31]
United States
CLOX CLOX divided in two parts: CLOX 1 (free draw of a clock) and CLOX 2 (copy of a clock) Stroke (n = 66, mean age, 58.8 y)
Right hemisphere (52%), left hemisphere (30%), bilateral (8%),
not defined (11%)
Test–retest reliability: CLOX 1, r = 0.62.CLOX 2, r = 0.68.
[82]
USA
Sorting Test, Color–Word Interference, TMT and EFPT Determinate the presence of ED immediately after mild stroke Mild stroke (n = 53, mean age, 56.2 y)
1 week after stroke
Not reported 66% of the subjects had poor performance in 1 out of 4, and 27% in 2 or more out of 4 measures of executive function
[46]
Poland
TMT,
VFT,
Go–No Go Task
WCST
Investigate the effect of lesion side (left/right) and location (anterior/posterior) on WCST scores Unilateral ischemic stroke (n = 44, mean age, 56 y) Not reported Worse performance in patients with frontal lesions
[35]
The Netherlands
ST and
Concept Shifting Test (CST)
Temporal relation between depressive symptoms and executive dysfunctions First-ever unilateral stroke (n = 116, mean age, 65.8 y) Not reported Depression and ED occurred in 22% of patients after 1 month.
33% of the patients with depression and ED still had symptoms after 2 years
[28]
United States
EFPT If the components of the EFPT are sensitive to impairments in executive abilities First-ever strokes
(n = 20, mean age, 58.8 y)
Inter-rater reliability:
ICC = 0.91
Internal Consistency:
α = 0.94
[25]
China
CFAB, ST, M-WCST, VFT and Go–No Go Task Correlation between executive function and emotional incontinence Stroke (n = 39, mean age, 63.8 y)
CG (n = 39, mean age, 64.4 y)
Not reported Emotional incontinence was associated with frontal or basal ganglia lesions.
[40]
United States
WCST, DS andDKEFS Frequency of ED.Relation between ED, stroke severity and premorbid risk factors Stroke (n = 47, mean age, 65.8 y)
TIA (n = 9, mean age, 64.1 y)
CG (n = 10, mean age, 58.5 y)
Not reported Impaired EF in 50% of subjects with stroke or TIA. Cognitive impairment was not related to stroke severity

EF = Executive Functions. ED = Executive Dysfunctions. LCSPT = inside the limbic–cortical–striatal–pallidal–thalamic circuit. n = number of subjects. CG = Control Group. TIA = Transient Ischemic Attack. y = years.

Table 2.

Executive Function assessment tools for executive dysfunction, evaluated in patients, 1–6 months after stroke.

Ref. Tools Objective Sample characteristics Psychometric data Main results
[17]
Finland
WCST,DS,TMT, VFT, and ST If the association of depression and ED increases the chances of a recurrent ischemic stroke First-ever ischemic stroke (n = 223, mean age, 71 y)
Only 205 performed EF evaluation
Not reported 83/205 (40%) presented ED.
The mean time until the first recurrent stroke was shorter for patients with depression and
patients with depression-executive dysfunction syndrome
[42]
South Korea
VFT,
DS and
ST
Investigate the patterns of the neuropsychological deficits, including EF Posterior cerebral artery (PCA) strokes (n = 12, mean age, 68.5 y) Not reported Stroke in the PCA territory was frequently associated with ED.
Extended lesions into the splenium of the corpus callosum and posterior ventral temporal lobe were associated with greater cognitive impairment
[19]
Finland
WCST,DS,TMT and ST Investigated the influence of post stroke depression and related factors on survival 3 months post stroke Stroke (n = 257, mean age, 71.9 y) Not reported ED was present in 114/257 (44.4%) patients and was associated with shorter survival. ED + depression were also associated with shorter survival
[48]
Finland
WCST,DS, VFTTMT and ST Patients with ED would have more often brain infarcts affecting the frontal–subcortical–circuit and more extensive white matter changes Stroke (n = 214, age range, 55–85 y) Not reported Number of infarcts in left hemisphere was higher in patients with ED.
ED was presented in 73 (34.1%).
21/73 had infarct in the pons. Moderate to severe white matter changes were often seen in patients with ED
ED was associated with lesions of the frontal–subcortical circuit
[33]
Finland
WCST,DS, VFTTMT and ST Depression-dysexecutive syndrome (DES) might be related to frontal–subcortical circuit dysfunction Ischemic stroke
(n = 158, age range, 55–85 y)
CG (n = 28, mean age, 67 y)
Not reported 53/158: presented ED
21/158 had DES; they showed significantly more brain infarcts affecting frontal–subcortical circuits, and also coped less well with complex activities of daily living
[47].
Finland
WCST,and ST Examine EF Ischemic stroke
(n = 256, mean age, 71.1 y)
Not reported Frequency of EF was 40.6%
(n = 104).
Patients with ED more often presented the following symptoms: low levels of education, poor performance in ADLs, cognitive impairment and dementia
[30]
United Kingdom
CAMCOG-R, Weighl and Raven tests Evaluate the concurrent validity: EF tests of the CAMCOG-R compared with
The Weighl and Raven tests
Stroke (n = 83, mean age, 75 y) Weighl: r = 0.46;
Raven: r = 0.59
[41]
Finland
TMT, ST, WCST and VFT If frontal stroke causes ED or slowing of mental processing Ischemic Stroke: frontal (n = 62, mean age, 70.9 y); Non-frontal (n = 188, mean age, 70.3 y);CG (n = 39, mean age, 66.5 y) Not reported EF was impaired in both frontal and non-frontal groups.
Mental processing was more impaired in the frontal group.

CG = Control Group. I = Ischemic. F = frontal; NF = Non-frontal. EF = Executive Functions. ED = Executive Dysfunctions. y = years. n = number of subjects.

Table 3.

Function assessment tools for executive dysfunction, evaluated in patients ≥ 6 months after stroke.

Ref. Tools Objective Sample characteristics Psychometric data Main results
[84]
Canada
TMT, DS Exercises and recreation could improve EF in adults with chronic stroke compared with a delayed intervention Stroke intervention
(INT, n = 12) or delayed intervention
(D-INT, n = 16)
Not reported Compared with the D-INT group, the INT group significantly improved selective attention and conflict resolution (P = .02), working memory (P = .04) at the end of the 6-month intervention period.
[29]
USA
DKEFS, Color–Word interference subtest, TMT and Letter–Number Sequencing Evaluate the association between executive function and coping strategies Stroke (n = 15, mean age, 60 y)
27% right stroke
73% left stroke
Not reported ED was not related to active coping
[32].
Israel
VAP-S, BADS,
Observed Tasks of Daily Living-Revised (OTDL-R)
Construct and Concurrent validity Right hemispheric
(n = 12)Left hemispheric
(n = 11)
Bilateral stroke
(n = 1)
(Mean age, 58.9 y)CG (n = 24, mean age, 60.1 y)
VAP-S (number of purchases) and:
BADS, r = 0.42;
OTDL-R, r = 0.64
VAP-S (correct actions) and:
BADS, r = 0.61;
OTDL-R, 0.68
OTDL-R and BADS: r = 0.72
Worse performance in patients than in controls in:
number of purchases and correct actions of the VAP-S; rule shift card, key search and modified 6-element tests of the BADS
[83]
The Netherlands
DS Associative working memory task is sensitive in stroke patients. Also, investigate the role of long-term encoding in relation to working memory. Stroke (n = 24, mean age:52.1 y) and
CG (n = 31, mean age: 50.6 y)
Not reported The binding condition was more difficult than both single-feature conditions, but patients performed equally well as compared to matched healthy controls. No deficits were found on the subsequent long-term memory task. Associative working memory may be mediated by structures of the medial temporal lobe.
[21]
Ireland
TMT, ST, Zoo Map (subtest of the BADS), Frontal Assessment Battery and DS Backwards How EF may affect performance on basic and complex 10 − meter gait tests Stroke (n = 20, mean age, 69.1 y)
Able to walk with or without an assistive device
Not reported Correlation between dysexecutive function and poor performance in the complex 10-meter gait test
[27]
United States
DS Backwards and Flanker Test Relation between improvement in aerobic fitness and changes in cognition and EF Stroke (n = 9, mean age, 63.7 y) Not reported Significant improvement in DS-B and FT performance after 12 weeks of the exercise program
[20].
Canada
TMT, ST and DS Backwards Exercises or practicing motor (included stretching, balance, and task-specific exercises) and recreation to improve EF and memory Stroke (n = 11, mean age, 67 y)
Lower Limb.
Able to walk 3 m with or without an assistive device
Not reported Significant improvement in the DS–B and ST after 6 months of the program of exercises and recreation
[22]
United States
EFPT, VTF, TMT, DS and Functional Independence Measure (FIM), among others Examine the reliability and validity of the EFPT Stroke (n = 73);
Mild (NIHSS = 2, n = 59, mean age, 64.5 y);
Moderate
(NIHSS = 10.6, n = 14, mean age, 64.1 y);
CG (n = 22, mean age, 59.4 y)
Inter-rater reliability:
ICC = 0.91;
Internal Consistency:
α = 0.94;
Concurrent validity: ATF (r = –0.47), TMT B (r = 0.39), DS Backward
(r = – 0.49); FIM
(r = − 0.40)
Subtests:
Cooking Task: ICC = 0.94;
Paying bills task: ICC = 0.89; Medication task: ICC = 0.87;
Telephone task: ICC = 0.79.
Construct validity: Performance of patients with moderate stroke was worse than performance of patients with milder stroke and even worse than of controls
[38]
Australia
BADS and Tinkertoy Test Performance in measures of executive functions employment and productivity outcomes Stroke (n = 27, mean age, 47.3 y) Not reported 10 patients returned to work in the 12-months follow-up and 17 did not.
The employed group performed better on the EF tests than the unemployed group
[37]
Canada
Stroop Test (ST) and
Digit Span test (DS)
Executive-controlled processes, performance
in balance and mobility
Stroke (n = 63, mean age, 65 y)
Able to walk for 10 m independently
Not reported Significant association between EF and balance
[34]
United Kingdom
Wisconsin Card Sorting Test (WCST), andControlled Oral Word Association (COWA) Examine the effect of antidepressants (nortriptyline and fluoxetine) on post-stroke EF Stroke (n = 30, mean age, 65.5 y) (nortriptyline or fluoxetine groups)
Placebo (n = 17, mean age, 71.7 y)
Not reported Both groups showed an improvement in EF after 21 weeks of treatment. Placebo group showed a decline in EF after 21 weeks

CG = Control Group. EF = Executive Functions. ED = Executive Dysfunctions. IADL = Instrumental Activities of Daily Living. NIHSS = National Institute of Health Stroke Scale. y = years. n = number of subjects.

Table 4.

Function assessment tools for executive dysfunction, evaluated in patients — time from stroke not specified.

Ref. Tools Objective Sample characteristics Psychometric data Main results
[39]
Australia
BADS and TMT Investigate the relation between executive functions and driving performance Stroke (n = 19, mean age, 70.1 y)
CG (n = 22, mean age, 64 y)
Not reported Moderate correlation between the TMT B and the driving score test
(rho = 0.34)
Control group performed better than stroke group in driving assessment
[45]
United States
Complex Task Performance Assessment (CPTA), DKEFS, M-WCST, VFT and TMT Evaluation of dysexecutive syndrome with the CPTA Stroke (n = 6, mean age, 55.7 y)
CG (n = 4, mean age, 55.7 y)
Not reported Stroke group performed worse in the CTPA then the CG
[24]
China
WCST, CFAB and Initiation–perseveration subtest of Mattis Evaluate validity and reliability of the CFAB Small subcortical infarct(n = 31, mean age, 73.5 y)
CG (n = 41, mean age, 69.6 y)
CFAB:
Internal consistency:
α = 0.77
Inter-rater reliability: rho = 0.85
Test–retest reliability: rho = 0.89
Concurrent Validity:
r = 0.63
Patients performed worse in the Mattis and the WCST, as well as in fluency, motor series and go–no-go items of the CFAB
[43]
The Netherlands
WCST, VFT, ST, DS, TLT Thalamic structures
have specific roles in each of these functions: memory, executive functioning and attention
Stroke
(n = 22, age between: 22 to 83 y)
Thalamic infarction (3 months to 24 years of lesion)
Not reported Thalamic structures are involved in memory, executive functioning and attention
[44]
United States
ST and
CCST
Evaluated ED could be found in non-demented patients with subcortical lacunar lesions Subcortical lacunar lesions. (n = 39, mean age, 73.7 y)
CG (n = 27, mean age, 72.8 y)
Not reported Stroke patients performed worse in ST and CCST.
Worse performance associated with more extensive lacunar lesions

CG = control group. EF = Executive Functions. ED = Executive Dysfunctions. y = years. n = number of subjects.

Table 5.

Tests and abbreviations.

Most cited test's name Abbreviations
Assessment of Motor and Process Skills AMPS
Behavioral Assessment of Dysexecutive Syndrome BADS
Cambridge Cognitive Examination — Revised CAMCOG-R
Chinese Frontal Assessment Battery C-FAB
Color–Word interference CWI
Controlled Oral Word Association COWA
Complex Task Performance Assessment CTPA
Concept Shifting Test CST
Delis–Kaplan Executive Function System DKEFS
Digit Span DS
Executive Clock Drawing Task CLOX
Executive Function Performance Test EFPT
Frontal Assessment Battery FAB
Initiation–perseveration subtest of Mattis IPS-Mattis
Letter–Number Sequencing LNS
Modified Wisconsin Card Sorting Test M-WCST
Observed Tasks of Daily Living-Revised OTDLR
Reven test RT
Stroop Test ST
Tinkertoy Test TT
Trail making TMT
Tower of London Test TLT
Verbal Fluency Test VFT
Virtual Action Planning — Supermarket VAP-S
Weigl test WT
Wisconsin Card Sorting Test WCST

3. Results

Initially, 210/997 abstracts were identified and 35/210 manuscripts were selected for this review (Fig. 1).

Fig. 1.

Fig. 1

Flow diagram: identified manuscripts and reasons for exclusion.

The results of 35 papers were organized according to time from stroke: Table 1 (up to one month, 11 studies), Table 2 (one-six months; eight studies) and Table 3 (6 months and more, eleven studies). Five manuscripts did not specify the period of evaluation after stroke onset (Table 4).

The tools most frequently used in the 35 studies identified were: Trail making Test (17) Stroop Test (15), Digit Span (15), Wisconsin Card Sorting Test (11), Verbal Fluency Test (11), and Behavioral Assessment of Dysexecutive Syndrome (4). In addition, most of the papers used more than one tool to evaluate executive functions. The most combined used instruments were: Trail Making Test, Digit Span and Verbal Fluency [16], [17], [18], Digit Span, Trail making and Stroop tests [19], [20], [21]; Digit Span tests [22], [23].

Modified versions of tests were reported in 6/35 manuscripts: Chinese Frontal Assessment Battery [24], [25] Modified Wisconsin Card Sorting Test [16], [17], [25] and Swedish version of the Executive Function Performance Test [26].

One or two subtests of the following instruments of evaluation were applied in 7/35 studies: Initiation-perseveration subtest of the Mattis Dementia Rating Scale [24]; Zoo map, from the Behavioral Assessment of Dysexecutive Syndrome [21]; Digit Span Backwards [21], [27]; Color–word Interference subtest [28], [29] and Executive Functions subtests of the Cambridge Cognitive Examination — Revised [30]. These subtests were used in addition to other tests to evaluate executive dysfunction.

Detailed psychometric properties of the Executive Function Performance Test were described for the English (six months or more after stroke and up to one month after stroke) and Swedish (up to one month after stroke) versions [22], [26], [28]. This test includes the following tasks: simple meal preparation, making a telephone call, paying the bills and taking medication. Therefore, it evaluates initiation, organization, sequence, safety and judgment, and conclusion of the task. The test had excellent inter-rater reliability (ICC = 0.91) [22], [28]. Internal consistency was also excellent (α = 0.94) [15].

Concurrent validity was poor when Executive Function Performance Test scores were correlated with scores in the Animal Fluency, Trail Making Test-B, Digit Span tests and the Functional Independence Measure [22], and moderate when correlated with the Assessment of Motor and Process Skills [26].

Psychometric properties of other executive dysfunction tests, listed below, were reported in four more studies (Table 1, Table 2, Table 3, Table 4):

  • Cambridge Cognitive Examination — Revised [30] (Table 2): This is a brief neuropsychology battery subdivided into eight subscales. It evaluates the following cognitive domains: orientation (time and place), language (comprehension and expression), memory (incidental, remote, recent and new learning), attention, calculation, praxis, perception and executive functions (abstract thinking, ideational fluency and visual reasoning). The instrument comprises a questionnaire as well as tasks. Leeds and colleagues described properties of two executive functions subtests (ideational fluency and visual reasoning). Concurrent validity was reported to be poor to moderate with the Weigl (r = 0.46) and Raven (r = 0.59) tests.

  • Executive Clock Drawing Task [31] (Table 1). The Executive Clock Drawing Task is divided into two parts: In Executive Clock Drawing Task 1, the patient is instructed to draw a clock on the back of the Executive Clock Drawing Task form. Executive Clock Drawing Task 2 consists of a simple copying task. The test–retest reliability was reported to be moderate (r = 0.62).

  • Chinese Frontal Assessment Battery [24] (Table 4), a bedside cognitive screening divided in six items that evaluate six executive domains conceptualization, mental flexibility, programming, sensitivity to interference, inhibitory control, and environmental autonomy. Moderate to very good psychometric properties were reported for the version in Chinese: for internal consistency, α = 0.77 and for inter-rater reliability, r = 0.89. Concurrent validity was evaluated by correlations between Chinese Frontal Assessment Battery scores and the number of categories completed (r = 0.45), and the number of perseverative errors (r = − 0.37) of the Wisconsin Card Sorting Test.

  • Virtual Action Planning — Supermarket [32] (Table 3), a virtual supermarket that evaluates the ability to buy seven items. The score is based on eight variables (total distance, total time, number of total items purchased, number of correct actions, number of incorrect actions, number of pauses, the combined duration of pauses and time to pay). Poor to moderate correlations were reported in the Hebrew version of the Virtual Action Planning — Supermarket (number of purchases) and the Behavioral Assessment of Dysexecutive Syndrome (r = 0.42) or the Observed Tasks of Daily Living-Revised (r = 0.64). Moderate correlations were reported between the Virtual Action Planning — Supermarket (correct actions) and the Behavioral Assessment of Dysexecutive Syndrome (r = 0.61) or the Observed Tasks of Daily Living-Revised (r = 0.68).

Relations between executive dysfunction and other conditions were discussed in 15/35 manuscripts: depression [17], [18], [19], [33], [34], [35], emotional incontinence [25], motor impairment and rehabilitation [20], [21], [27], [36], [37], coping [29], employment/productivity outcomes [38] and driving performance [39]. Altogether, patients with executive dysfunction presented poor performance on physical tasks often had depression and difficulties to return to a productive life. Long-term antidepressant treatment improved executive function in patients with stroke [34]. Only a few studies mentioned effects of antidepressants in their studies [18], [35]. On the other hand, executive dysfunction was not significantly correlated with emotional incontinence or coping after stroke.

Executive dysfunction was compared in patients with stroke and in controls in 12/35 manuscripts: three, less than 1 month after stroke [16], [25], [40]; two, one-six months [33], [41]; four, six months or more [22, 32,34, 51]; four, time from stroke not specified [24], [39], [44], [45]. Overall, as expected, executive function was worse in patients than in controls [16], [22], [24], [25], [32], [39], [40], [41], [44], [46].

Lesion sites were described in only 11/35 manuscripts: frontal or non-frontal [23], [41]; frontal–subcortical circuit [48]; cortical or subcortical territory of the posterior cerebral artery [42]; “posterior region” [16]; right, left or bilateral stroke [31], [32]; right and left side [29]; stroke inside the limbic–cortical–striatal–pallidal–thalamic circuit (LCSPT) [18], subcortical lacunes [44] and thalamic infarcts [43]. The latter study revealed an association between lesions in the LCSPT circuit and depression, but not executive dysfunction, in patients over 60 years [18]. Three manuscripts investigated executive dysfunction in patients with frontal or non-frontal lesions [23], [41]. Differences between these two groups of patients were found in two studies [16], [41]. Lesions in the territory of the posterior cerebral artery were frequently associated with executive dysfunction [42]. In addition, executive dysfunction was associated with lesions in the frontal–subcortical circuit [48].

4. Discussion

The present study demonstrates that, in contrast to the extensive literature on motor function after stroke, the number of studies specifically evaluating executive function/dysfunction in stroke is relatively small (N = 35). These studies used a diverse range of assessment tools, and only a few provided adequate information on the psychometric properties of the tests employed. Literally all studies were performed in high-income, mostly western countries, despite the fact that most strokes occur in low- and middle-income countries. The study further shows that various assessment tools were used for different stages of recovery. And while most studies reported time since stroke at the point of assessment, the evidence-base available does not specifically address how stroke chronicity might have affected test performance. Several papers further highlighted the shortcomings of the evidence base concerning the association between executive dysfunction and other types of impairment, as well as rehabilitation interventions [18], [19], [20], [21], [25], [29], [34], [35], [37]. Moreover, more studies with larger sample sizes are necessary to improve the evidence base, and indeed, clinical practice in the area of executive function in stroke.

The most frequently reported tools for assessment of executive function were the Trail Making Test, Stroop test, and Digit Span tests. They evaluate different aspects of executive functions. Digit Forward is a measure of attention and immediate memory, while Digit Backwards is related to more complex attention and working memory. Trail Making Test A is related to processing speed and flexibility, while Trail making B is a measure of mental flexibility, sustaining, shifting and dividing attention. The Stroop test is used to verify inhibitory control. Together these tests therefore provide an easy and quick to administer, yet relatively good estimate of executive function. However, despite the practical advantageous of those tests in clinical settings, their psychometric properties were not yet characterized in patients with stroke.

Psychometric properties of the Stroop test and the Trail Making Test were described for healthy subjects in different languages, including English [49], [50], Swiss-German [51], Portuguese [52], [53], and Italian [54]. Psychometric properties of the Trail making test were further described for patients with brain damage in various languages [55], [56]. Future research is required to define internal consistency, inter-rater and test–retest reliabilities, as well as discriminating, construct and concurrent validities of these instruments in patients with stroke, at different stages of recovery and with particular lesion locations. Moreover, it is important to consider the influence of motor or language impairment on test performance as well as the influence of educational level. The latter is particularly important in low-income countries where reading and writing skills are often quite poor.

Psychometric properties in patients with stroke were comprehensively described for the Executive Function Performance Test. This test had excellent inter-rater reliability and internal consistency. It was compared with measures of executive functions (Animal Fluency, Trail making Test-B, Digit Span tests and the Functional Independence Measure) [22], as well as performance-based tools for Activities of Daily Living and executive functions (Assessment of Motor and Process Skills) [26]. Concurrent validity was found to be moderate.

Besides the Executive Function Performance Test, psychometric properties were described for only four other instruments in patients with stroke. Test–retest reliability was reported to be moderate for the Executive Clock Drawing Task and was not described for other tests. Inter-rater reliability was excellent for the Chinese Frontal Assessment Battery, but not reported in other tests. Internal consistency was very good for the Chinese Frontal Assessment Battery. Moderate concurrent validities were described for executive functions subtests of the Cambridge Cognitive Examination — Revised [20], Chinese Frontal Assessment Battery [24] or Virtual Action Planning — Supermarket [32] and other tests.

As the discussion above highlights, psychometric data for executive function tests in stroke are insufficient, and this is a recognized demand. The NIH EXAMINER represents a new test battery for executive functions for neurological disease which has recently been validated in a multicentre study validated with 1248 participants (included 485 participants below the age of 18 years and 763 participants 18 years and older) [57], [58], [59]. However, patients with stroke were not included. Considering the impact of executive dysfunction in patients with stroke, we suggest that this instrument should be translated, validated and adapted to different cultures worldwide.

Executive function is a complex cognitive domain that influences and is influenced by other human functions such as behavior and emotional, motor and other cognitive domains. Executive dysfunction can compromise functional status, due to the interaction with other conditions such as depression [18], [19], [34], [35], emotional incontinence [25], motor impairments [20], [21], [27], [36] and driving performance [39]. In addition, impairment in these conditions can lead to poorer quality of life. Moreover, executive function can interfere in daily routine, including the capacity to deal with unfamiliar situations in new environments.

In particular, executive function is frequently impaired in elderly patients with depression [60], and is a predictor of depression [61], [62]. Even after treatment of depression, impairments in executive functions can persist and are associated with worse outcomes [60]. Depression is common after stroke, with prevalence ranging from 25% to 70% in all survivors [63]. Therefore, patients may simultaneously present executive dysfunction and depression (co-morbid prevalence of 18.3%) [17], [18], [19], [33], [61]. Considering that depression and executive dysfunction interact with each other and are associated with poor outcomes after stroke, studies that report performance in executive function in patients with stroke should also investigate symptoms of depression.

Not only depression interferes on executive dysfunction after stroke, but also medication used for treatment may interfere with performance of the patient [64]. For this reason, medication should be considered during evaluations in clinical practice and in research studies in general; however not all studies described medications used.

In addition, not only the stroke lesion itself, but also vascular cognitive impairment can contribute to executive dysfunction [65]. Vascular cognitive impairment in non-demented patients is characterized by cognitive decline secondary to cerebrovascular disease and can present with executive dysfunction [66], [67], [68]. The rate of vascular cognitive impairment ranges from 10.5 to 37% of patients without stroke or dementia [69], [70], [71]. In Brazil, for instance, vascular cognitive impairment in patients with ischemic stroke was diagnosed in 16.8% of 172 subjects [72]. It is important that studies about executive function in patients with stroke define whether vascular cognitive impairment was an exclusion criterion.

Finally, details about lesion sites were scarce or absent in most studies that reported evaluation of executive dysfunction in patients with stroke. It is desirable that more information about lesion location is provided in future studies. Two studies used magnetic resonance imaging (MRI) for lesion characterization and compared the result with the measures for executive dysfunction [33], [48]. Patients with executive dysfunction presented infarcts in the frontal–sub cortical circuit [48]. In addition, the aging brain suffers changes such as white matter lesions and microbleeds, which are associated with cognitive and functional decline [67].

Stroke is not the only cerebrovascular diseases that can cause cognitive impairment. White matter lesions [73] and cerebral microbleeds [74] may play an important role. White matter lesions are prevalent in people over 60 years, can be detected in up to 90% of neurologically symptom-free elderly and are associated with cognitive impairment [75], [76]. Cerebral microbleeds are focal lesions that result from a deposit of hemosiderin that presumably leaks out from damaged small brain vessels [74]. The prevalence of cerebral microbleeds was estimated as 17.8% in persons aged 60–69 years, and 38.3% in people over 80 years [74]. The presence of numerous microbleeds correlates with worse cognitive performance [77]. Moreover, lobar microbleeds are independently associated with executive dysfunction in patients with stroke or transient ischemic attacks [77]. Executive dysfunction is more prevalent in patients with cerebral microbleeds (38%) than other cognitive impairments [78].

A limitation of this study was to only include articles published in English. Despite this, very few manuscripts published in other languages were identified: in Portuguese [79] and in Norwegian [80]. Manuscripts reporting scales in languages other than English may have been published in journals not indexed in Medline, Pubmed and Google Scholar. This limits evaluation of validity and cross-cultural comparisons.

It is further noteworthy that literally all studies included in this review excluded patients with language impairments and those with severe physical disabilities. The findings on executive function performance summarized here are therefore not entirely translatable to the stroke population as a whole.

In a recent systematic review about cognitive rehabilitation after stroke, the authors discussed the importance of cognitive rehabilitation and the lack of evidence in this area [81]. Moreover, the review revealed that some of the cognitive domains (attention, spatial neglect and motor apraxia) can improve with rehabilitation, but this improvement is not long lasting. The authors also described the major limitations of evidence and the need for more investigations in this area with appropriate methodological standards.

5. Conclusion

Appropriate assessment of the patient with stroke is essential to provide better treatments. Awareness and quantification of impairments can enhance the ability to plan rehabilitation and optimize long-term care provision, in order to tailor treatments according to specific individual needs. This is particularly important for patients who might be able to return to work if their deficits in cognition are recognized. To attain this goal, adequate tools of evaluation, adapted to local cultural specificities, are required. There is a paucity of tools to reliably measure executive dysfunction after stroke, despite the fact that executive dysfunction is frequent. Specifically, there is a great need to develop appropriate tools for developing countries. In addition, limited information is available about the relation between executive dysfunction measured with valid scales and stroke lesions, white matter disease, microbleeds, as well as with other conditions that can be associated with stroke such as vascular cognitive impairment and depression. There are deep gaps about executive dysfunction in stroke, to be filled in research and in clinical practice.

Funding

Annette Sterr, PhD is a Visitor Professor Neurostimulation Laboratory, Neurology Department at São Paulo University and received a “Science Without Boarders” scholarship (GRANT A 068/2013) from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior (CAPES). This investigation was supported by the Fogarty International Center of the National Institutes of Health under the NCD-LIFESPAN program (GRANT D71TW009132-01). Juliana Conti and Adriana Bastos Conforto received funding from the National Institutes of Neurological Disorders and Stroke (R01NS076348-01).

Conflict of interest

The authors declare that there are no conflicts of interest.

Acknowledgment

Annette Sterr, PhD and Adriana Bastos Conforto, MD, PhD contributed equally to this manuscript.

References

  • 1.Warlow C., Gijn J.V., Dennis M., Wardlaw J., Bamford J., Hankey G. 3rd edition. Blackwell Publishing Lta; 2011. Stroke Practical Management; pp. 35–130. [Google Scholar]
  • 2.World Health Organization 2012. http://www.who.int/topics/cerebrovascular_accident/en/ Retrieved from:
  • 3.Feigin VL, Forouzanfar M.H., Krishnamurthi R., Mensah G.A., Connor M., Bennett D.A., Moran A.E., Sacco R.L., Anderson L., Truelsen T. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–254. doi: 10.1016/s0140-6736(13)61953-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brass L.M., Fayad P.B., Levine S.R. Transient ischemic attacks in the elderly: diagnosis and treatment. Geriatrics. 1992;47(5):36–53. [PubMed] [Google Scholar]
  • 5.Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018. doi: 10.1016/S1474-4422(09)70236-4. [DOI] [PubMed] [Google Scholar]
  • 6.Nys G.M., van Zandvoort M.J., de Kort P.L., Jansen B.P., de Haan E.H., Kappelle L.J. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc. Dis. 2007;23(5-6):408–416. doi: 10.1159/000101464. [DOI] [PubMed] [Google Scholar]
  • 7.Barker-Collo S., Feigin V.L., Parag V., Lawes C.M., Senior H. Auckland Stroke Outcomes Study. Part 2: Cognition and functional outcomes 5 years poststroke. Neurology. 2010;75(18):1608–1616. doi: 10.1212/WNL.0b013e3181fb44c8. [DOI] [PubMed] [Google Scholar]
  • 8.Leśniak M., Bak T., Czepiel W., Seniów J., Członkowska A. Frequency and prognostic value of cognitive disorders in stroke patients. Dement. Geriatr. Cogn. Disord. 2008;26(4):356–363. doi: 10.1159/000162262. [DOI] [PubMed] [Google Scholar]
  • 9.Poulin V., Korner-Bitensky N., Dawson D.R., Bherer L. Efficacy of executive function interventions after stroke: a systematic review. Top. Stroke Rehabil. 2012;19(2):158–171. doi: 10.1310/tsr1902-158. [DOI] [PubMed] [Google Scholar]
  • 10.Elliott R. Executive functions and their disorders. Br. Med. Bull. 2003;65:49–59. doi: 10.1093/bmb/65.1.49. [DOI] [PubMed] [Google Scholar]
  • 11.Burgess P.W., Simons J.S. Theories of frontal lobe executive function: clinical applications. In: Halligam P.W., Wade D.T., editors. Effectiveness of Rehabilitation for Cognitive Deficits. Oxford University Press; Oxford: 2009. pp. 211–251. [Google Scholar]
  • 12.Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn. Psychol. 2000;41:49–100. doi: 10.1006/cogp.1999.0734. [DOI] [PubMed] [Google Scholar]
  • 13.Miyake A., Emerson M.J., Friedman N.P. Assement of executive functions in clinical settings: problems and recommendations. Semin. Speech Lang. 2000;21(2) doi: 10.1055/s-2000-7563. [DOI] [PubMed] [Google Scholar]
  • 14.Preferred Reporting Items for Systematic Reviews and Meta-Analyses — PRISMA. 2013. http://www.prisma-statement.org/ Retrieved from:
  • 15.Dawson B., Trapp R.G. 3rd edition. Mc Graw Hill; 2001. Bioestatistica Básica e Clinica. (350 pp.) [Google Scholar]
  • 16.Roussel M., Dujardin K., Hénon H., Godefroy O. Is the frontal dysexecutive syndrome due to a working memory deficit? Evidence from patients with stroke. Brain. 2012;135(Pt 7):2192–2201. doi: 10.1093/brain/aws132. [DOI] [PubMed] [Google Scholar]
  • 17.Sibolt G., Curtze S., Melkas S., Pohjasvaara T., Kaste M., Karhunen P.J., Oksala N.K., Vataja R., Erkinjuntti T. Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke. Cerebrovasc. Dis. 2013;36(5-6):336–343. doi: 10.1159/000355145. [DOI] [PubMed] [Google Scholar]
  • 18.Sobreiro M.F., Miotto E.C., Terroni L., Tinone G., Iosifescu D.V., de Lucia M.C., Scaff M., Leite C.C., Amaro E., Fraguas R. Executive function and depressive symptoms of retardation in nonelderly stroke patients. J. Clin. Exp. Neuropsychol. 2014;36(6):636–647. doi: 10.1080/13803395.2014.925092. [DOI] [PubMed] [Google Scholar]
  • 19.Melkas S., Vataja R., Oksala N.K., Jokinen H., Pohjasvaara T., Oksala A., Leppävuori A., Kaste M., Karhunen P.J., Erkinjuntti T. Depression-executive dysfunction syndrome relates to poor poststroke survival. Am. J. Geriatr. Psychiatr. 2010;18(11):1007–1016. doi: 10.1097/JGP.0b013e3181d695d7. [DOI] [PubMed] [Google Scholar]
  • 20.Rand D., Eng J.J., Liu-Ambrose T., Tawashy A.E. Feasibility of a 6-month exercise and recreation program to improve executive functioning and memory in individuals with chronic stroke. Neurorehabil. Neural Repair. 2010;24(8):722–729. doi: 10.1177/1545968310368684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hayes S., Donnellan C., Stokes E. Associations between executive function and physical function poststroke: a pilot study. Physiotherapy. 2013;99(2):165–171. doi: 10.1016/j.physio.2012.05.002. [DOI] [PubMed] [Google Scholar]
  • 22.Baum C.M., Connor L.T., Morrison T., Hahn M., Dromerick A.W., Edwards D.F. Reliability, validity, and clinical utility of the Executive Function Performance Test: a measure of executive function in a sample of people with stroke. Am. J. Occup. Ther. 2008;62(4):446–455. doi: 10.5014/ajot.62.4.446. [DOI] [PubMed] [Google Scholar]
  • 23.Tamez E., Myerson J., Morris L., White D.A., Baum C., Connor L.T. Assessing executive abilities following acute stroke with the trail making test and digit span. Behav. Neurol. 2011;24(3):177–185. doi: 10.3233/BEN-2011-0328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mok V.C., Wong A., Yim P., Fu M., Lam W.W., Hui A.C., Yau C., Wong K.S. The validity and reliability of chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis. Assoc. Disord. 2004;18(2):68–74. doi: 10.1097/01.wad.0000126617.54783.7. [DOI] [PubMed] [Google Scholar]
  • 25.Tang W.K., Chen Y., Lam W.W., Mok V., Wong A., Ungvari G.S., Xiang Y.T., Wong K.S. Emotional incontinence and executive function in ischemic stroke: a case-controlled study. J. Int. Neuropsychol. Soc. 2009;15(1):62–68. doi: 10.1017/S1355617708090061. [DOI] [PubMed] [Google Scholar]
  • 26.Cederfeldt M., Widell Y., Anderson E.E., Dahlin-Ivanoff S., Gosman-Hedström G. Concurrent validity of the Executive Function Performance Test in people with mild stroke. Br. J. Occup. Ther. 2011;74(9) [Google Scholar]
  • 27.Kluding P.M., Tseng B.Y., Billinger S.A. Exercise and executive function in individuals with chronic stroke: a pilot study. J. Neurol. Phys. Ther. 2011;35(1):11–17. doi: 10.1097/NPT.0b013e318208ee6c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wolf T.J., Stift S., Connor L.T., Baum C. Cognitive rehabilitation research group. Feasibility of using the EFPT to detect executive function deficits at the acute stage of stroke. Work. 2010;36(4):405–412. doi: 10.3233/WOR-2010-1045. [DOI] [PubMed] [Google Scholar]
  • 29.Kegel J., Dux M., Macko R. Executive function and coping in stroke survivors. NeuroRehabilitation. 2014;34(1):55–63. doi: 10.3233/NRE-131010. [DOI] [PubMed] [Google Scholar]
  • 30.Leeds L., Meara R.J., Woods R., Hobson J.P. A comparison of the new executive functioning domains of the CAMCOG-R with existing tests of executive function in elderly stroke survivors. Age Ageing. 2001;30(3):251–254. doi: 10.1093/ageing/30.3.251. [DOI] [PubMed] [Google Scholar]
  • 31.Zuverza-Chavarria V., Tsanadis J. Measurement properties of the CLOX Executive Clock Drawing Task in an inpatient stroke rehabilitation setting. Rehabil. Psychol. 2011;56(2):138–144. doi: 10.1037/a0023465. [DOI] [PubMed] [Google Scholar]
  • 32.Josman N., Kizony R., Hof E., Goldenberg K., Weiss P.L., Klinger E. Using the virtual action planning-supermarket for evaluating executive functions in people with stroke. J. Stroke Cerebrovasc. Dis. 2014;23(5):879–887. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.013. [DOI] [PubMed] [Google Scholar]
  • 33.Vataja R., Pohjasvaara T., Mäntylä R., Ylikoski R., Leskelä M., Kalska H., Hietanen M., Juhani Aronen H., Salonen O., Kaste M. Depression-executive dysfunction syndrome in stroke patients. Am. J. Geriatr. Psychiatr. 2005;13(2):99–107. doi: 10.1176/appi.ajgp.13.2.99. [DOI] [PubMed] [Google Scholar]
  • 34.Narushima K., Paradiso S., Moser D.J., Jorge R., Robinson R.G. Effect of antidepressant therapy on executive function after stroke. Br. J. Psychiatry. 2007;190:260–265. doi: 10.1192/bjp.bp.106.025064. [DOI] [PubMed] [Google Scholar]
  • 35.Bour A., Rasquin S., Limburg M., Verhey F. Depressive symptoms and executive functioning in stroke patients: a follow-up study. Am. J. Geriatr. Psychiatr. 2011;26(7):679–686. doi: 10.1002/gps.2581. [DOI] [PubMed] [Google Scholar]
  • 36.Liu- Ambrose T., Eng J.J. Exercise training and recreational activities to promote executive functions in chronic stroke: a proof-of-concept study. J. Stroke Cerebrovasc. Dis. 2015;24(1):130–137. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Liu-Ambrose T., Pang M.Y., Eng J.J. Executive function is independently associated with performances of balance and mobility in community-dwelling older adults after mild stroke: implications for falls prevention. Cerebrovasc. Dis. 2007;23(2-3):203–210. doi: 10.1159/000097642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ownsworth T., Shum D. Relationship between executive functions and productivity outcomes following stroke. Disabil. Rehabil. 2008;30(7):531–540. doi: 10.1080/09638280701355694. [DOI] [PubMed] [Google Scholar]
  • 39.Motta K., Lee H., Falkmer T. Post-stroke driving: examining the effect of executive dysfunction. J. Saf. Res. 2014;49:33–38. doi: 10.1016/j.jsr.2014.02.005. [DOI] [PubMed] [Google Scholar]
  • 40.Zinn S., Bosworth H.B., Hoenig H.M., Swartzwelder H.S. Executive function deficits in acute stroke. Arch. Phys. Med. Rehabil. 2007;88(2):173–180. doi: 10.1016/j.apmr.2006.11.015. [DOI] [PubMed] [Google Scholar]
  • 41.Leskelä M., Hietanen M., Kalska H., Ylikoski R., Pohjasvaara T., Mäntylä R., Erkinjuntti T. Executive functions and speed of mental processing in elderly patients with frontal or nonfrontal ischemic stroke. Eur. J. Neurol. 1999;6(6):653–661. doi: 10.1046/j.1468-1331.1999.660653.x. [DOI] [PubMed] [Google Scholar]
  • 42.Park K.C., Yoon S.S., Rhee H.Y. Executive dysfunction associated with stroke in the posterior cerebral artery territory. J. Clin. Neurosci. 2011;18(2):203–208. doi: 10.1016/j.jocn.2010.05.026. [DOI] [PubMed] [Google Scholar]
  • 43.Van der Werf Y.D., Scheltens P., Lindeboomc J., Witter M.P., Uylings H.M.B., Jolles J. Deficits of memory, executive functioning and attention following infarction in the thalamus; a study of 22 cases with localised lesions. Neuropsychologia. 2003;41:1330–1344. doi: 10.1016/s0028-3932(03)00059-9. [DOI] [PubMed] [Google Scholar]
  • 44.Kramer J.H., Reed B.R., Mungas D., Weiner M.W., Chui H.C. Executive dysfunction in subcortical ischaemic vascular disease. J. Neurol. Neurosurg. Psychiatry. 2002;72(2):217–220. doi: 10.1136/jnnp.72.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wolf T.J., Morrison T., Matheson L. Initial development of a work-related assessment of dysexecutive syndrome: the Complex Task Performance Assessment. Work. 2008;31(2):221–228. [PubMed] [Google Scholar]
  • 46.Jodzio K., Biechowska D. Wisconsin card sorting test as a measure of executive function impairments in stroke patients. Appl. Neuropsychol. 2010;17(4):267–277. doi: 10.1080/09084282.2010.525104. [DOI] [PubMed] [Google Scholar]
  • 47.Pohjasvaara T., Leskelä M., Vataja R., Kalska H., Ylikoski R., Hietanen M., Leppävuori A., Kaste M., Erkinjuntti T. Post-stroke depression, executive dysfunction and functional outcome. Eur. J. Neurol. 2002;9(3):269–275. doi: 10.1046/j.1468-1331.2002.00396.x. [DOI] [PubMed] [Google Scholar]
  • 48.Vataja R., Pohjasvaara T., Mäntylä R., Ylikoski R., Leppävuori A., Leskelä M., Kalska H., Hietanen M., Aronen H.J., Salonen O., Kaste M. Erkinjuntti T MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur. J. Neurol. 2003;10(6):625–631. doi: 10.1046/j.1468-1331.2003.00676.x. [DOI] [PubMed] [Google Scholar]
  • 49.Reitan R.M. Validity of the Trail Making test as an indicator of organic brain damage. Percept. Mot. Skills. 1958;8:271–276. [Google Scholar]
  • 50.Gaudino E.A., Geisler M.W., Squires N.K. Construct validity in the Trail Making Test: what makes Part B harder? J. Clin. Exp. Neuropsychol. 1995;17(4):529–535. doi: 10.1080/01688639508405143. [DOI] [PubMed] [Google Scholar]
  • 51.Siegrist M. Reliability of the stroop test with single-stimulus presentation. Percept. Mot. Skills. 1995;81(3 Pt 2):1295–1298. doi: 10.2466/pms.1995.81.3f.1295. [DOI] [PubMed] [Google Scholar]
  • 52.Capovilla A.G.S., Montiel J.M., Macedo E.C., Charin S. University São Francisco; Itatiba, São Paulo: 2005. Computerized Stroop Test. [Google Scholar]
  • 53.Kulaif T., Valle L.E. Alternative to the Stroop Color–Word Test for illiterate individuals. Clin. Neuropsychol. 2008;22(1):73–83. doi: 10.1080/13854040601186964. [DOI] [PubMed] [Google Scholar]
  • 54.Giovagnoli A.R., Del Pesce M., Mascheroni S., Simoncelli M., Laiacona M., Capitani E. Trail making test: normative values from 287 normal adult controls. Ital. J. Neurol. Sci. 1996;17(4):305–309. doi: 10.1007/BF01997792. [DOI] [PubMed] [Google Scholar]
  • 55.Reitan R.M. Trail making test results for normal and brain-damaged children. Percept. Mot. Skills. 1971;33:571–581. doi: 10.2466/pms.1971.33.2.575. [DOI] [PubMed] [Google Scholar]
  • 56.Wagner S., Helmreich I., Dahmen N., Lieb K., Tadic A. Reliability of three alternate forms of the trail making tests A and B. Arch. Clin. Neuropsychol. 2011;26(4):314–321. doi: 10.1093/arclin/acr024. [DOI] [PubMed] [Google Scholar]
  • 57.Kramer J.H., Mungas D., Possin K.L., Rankin K.P., Boxer A.L., Rosen H.J., Bostrom A., Sinha L., Berhel A., Widmeyer M. NIH EXAMINER: conceptualization and development of an executive function battery. J. Int. Neuropsychol. Soc. 2014;20(1):11–19. doi: 10.1017/S1355617713001094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Possin K.L., LaMarre A.K., Wood K.A., Mungas D.M., Kramer J.H. Ecological validity and neuroanatomical correlates of the NIH EXAMINER executive composite score. J. Int. Neuropsychol. Soc. 2014;20(1):20–28. doi: 10.1017/S1355617713000611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Robinson H., Calamia M., Gläscher J., Bruss J., Tranel D. Neuroanatomical correlates of executive functions: a neuropsychological approach using the EXAMINER battery. J. Int. Neuropsychol. Soc. 2014;20(1):52–63. doi: 10.1017/S135561771300060X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Alexopoulos G.S., Kiosses D.N., Heo M., Murphy C.F., Shanmugham B., Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol. Psychiatry. 2005;58:204–210. doi: 10.1016/j.biopsych.2005.04.024. [DOI] [PubMed] [Google Scholar]
  • 61.Terroni L., Sobreiro M.F.M., Conforto A.B., Adda C.C., Guajardo V.D., Lucia M.C. Association among depression, cognitive impairment and executive dysfunction after stroke. Dement. Neuropsychol. 2012;6(3):152–157. doi: 10.1590/S1980-57642012DN06030007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ojagbemi A., Akinyemi R., Baiyewu O. Cognitive dysfunction and functional limitations are associated with major depression in stroke survivors attending rehabilitation in Nigeria. NeuroRehabilitation. 2014;34(3):455–461. doi: 10.3233/NRE-141061. [DOI] [PubMed] [Google Scholar]
  • 63.Taylor-Piliae R.E., Hepworth J.T., Coull B.M. Predictors of depressive symptoms among community-dwelling stroke survivors. J. Cardiovasc. Nurs. 2013;28(5):460. doi: 10.1097/JCN.0b013e318258ad57. [DOI] [PubMed] [Google Scholar]
  • 64.Culang-Reinlieb M.E., Sneed J.R., Keilp J.G., Roose S.P. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. Int. J. Geriatr. Psychiatry. 2012;27(8):777–784. doi: 10.1002/gps.2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Tu Q., Ding B., Yang X., Bai S., Tu J., Liu X., Wang R., Tao J., Jin H., Wang Y. The current situation on vascular cognitive impairment after ischemic stroke in Changsha. Arch. Gerontol. Geriatr. 2014;58(2):236–247. doi: 10.1016/j.archger.2013.09.006. [DOI] [PubMed] [Google Scholar]
  • 66.Andrade S.P., Brucki S.M., Bueno O.F., Siqueira Neto J.I. Neuropsychological performance in patients with subcortical stroke. Arq. Neuropsiquiatr. 2012;70(5):341–347. doi: 10.1590/s0004-282x2012005000012. [DOI] [PubMed] [Google Scholar]
  • 67.Sudo F.K., Alves C.E.O., Alves G.S., Ericeira-Valente L., Moreira Tiel C., Laks J, Engelhardt E. D.M. Dysexecutive syndrome and cerebrovascular disease in non-amnestic mild cognitive impairment a systematic review of the literature. Dement. Neuropsychol. 2012;6(3):145–151. doi: 10.1590/S1980-57642012DN06030006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Vasquez B.P., Zakzanis K.K. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J. Neuropsychol. 2015;9(1):109–136. doi: 10.1111/jnp.12039. [DOI] [PubMed] [Google Scholar]
  • 69.Di Carlo A., Baldereschi M., Amaducci L., Maggi S., Grigoletto F., Scarlato G., Inzitari D. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J. Am. Geriatr. Soc. 2000;48(7):775–782. doi: 10.1111/j.1532-5415.2000.tb04752.x. [DOI] [PubMed] [Google Scholar]
  • 70.Rockwood K., Wentzel C., Hachinski V., Hogan D.B., MacKnight C., McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000;54(2):447–451. doi: 10.1212/wnl.54.2.447. [DOI] [PubMed] [Google Scholar]
  • 71.Partridge J.S., Dhesi J.K., Cross J.D., Lo J.W., Taylor P.R., Bell R., Martin F.C., Harari D. The prevalence and impact of undiagnosed cognitive impairment in older vascular surgical patients. J. Vasc. Surg. 2014;60(4):1002–1011. doi: 10.1016/j.jvs.2014.04.041. [DOI] [PubMed] [Google Scholar]
  • 72.Brucki S.M.D., Machado M.F., Rocha M.S.G. Vascular Cognitive Impairment (VCI) after non-embolic ischemic stroke during a 12-month follow-up in Brazil. Dement. Neuropsychol. 2012;6(3):164–169. doi: 10.1590/S1980-57642012DN06030009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Fazekas F., Wardlaw J.M. The origin of white matter lesions: a further piece to the puzzle. Stroke. 2013;44(4):951–952. doi: 10.1161/STROKEAHA.111.000849. [DOI] [PubMed] [Google Scholar]
  • 74.Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski P.A., Niessen W.J., Hofman A., Krestin G.P., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–1214. doi: 10.1212/01.wnl.0000307750.41970.d9. [DOI] [PubMed] [Google Scholar]
  • 75.Nichtweiss M., Weidauer S., Treusch N., Hattingen E. White matter lesions and vascular cognitive impairment: part 1: typical and unusual causes. Clin. Neuroradiol. 2012;22(3):193–210. doi: 10.1007/s00062-012-0134-5. [DOI] [PubMed] [Google Scholar]
  • 76.Bolandzadeh N., Davis J.C., Tam R., Handy T.C., Liu-Ambrose T. The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol. 2012;12:126. doi: 10.1186/1471-2377-12-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Poels M.M., Ikram M.A., van der Lugt A., Hofman A., Niessen W.J., Krestin G.P., Breteler M.M., Vernooij M.W. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78(5):326–333. doi: 10.1212/WNL.0b013e3182452928. [DOI] [PubMed] [Google Scholar]
  • 78.Gregoire S.M., Smith K., Jäger H.R., Benjamin M., Kallis C., Brown M.M., Cipolotti L., Werring D.J. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc. Dis. 2012;33(5):430–435. doi: 10.1159/000336237. [DOI] [PubMed] [Google Scholar]
  • 79.Gindri G., Zibetti M.R., Fonseca R.P. Funções executivas pós-lesão de hemisfério direito: estudo comparativo e frequência de déficits. Psic. 2008;39(3):282–291. [Google Scholar]
  • 80.Engstad R.T., Engstad T.T., Davanger S., Wyller T.B. Executive function deficits following stroke. Tidsskr. Nor. Laegeforen. 2013;133(5):524–527. doi: 10.4045/tidsskr.12.0686. [DOI] [PubMed] [Google Scholar]
  • 81.Gillespie D.C., Bowen A., Chung C.S., Cockburn J., Knapp P., Pollock A. Rehabilitation for post-stroke cognitive impairment: an overview of recommendations arising from systematic reviews of current evidence. Clin. Rehabil. 2015;29(2):120–128. doi: 10.1177/0269215514538982. [DOI] [PubMed] [Google Scholar]
  • 82.Wolf T.J., Barbee A.R., White D. Executive dysfunction immediately after mild stroke. OTJR (Thorofare N J) 2011;31(1):S23–S29. doi: 10.3928/15394492-20101108-05. [DOI] [PubMed] [Google Scholar]
  • 83.van Geldorp B., Kesselsa R.P.C., Hendriks M.P.H. Single-item and associative working memory in stroke patients. Behav. Neurol. 2013;26:199–201. doi: 10.3233/BEN-2012-129010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Liu-Ambrose T., Eng J.J. Exercise training and recreational activities to promote executive functions in chronic stroke: a proof-of-concept study. J Stroke Cerebrovasc Dis. 2015 Jan;24(1):130–137. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from eNeurologicalSci are provided here courtesy of Elsevier

RESOURCES